Quick Answer
ImageneBio, Inc. reported Total Revenue of $800.0 thousand for fiscal year 2025.
ImageneBio, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $800.0K | -77.1% |
| 2024 | $3.50M | -61.8% |
| 2023 | $9.16M | -41.3% |
| 2022 | $15.62M | -49.6% |
| 2021 | $30.98M | +237.0% |
| 2020 | $9.19M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $3.50M | +195.4% | +195.4% |
| September 30, 2023 | $1.19M | -81.5% | -40.9% |
| June 30, 2023 | $2.00M | +424.6% | -62.3% |
| March 31, 2023 | $5.31M | +57.0% | -17.0% |
| September 30, 2022 | $6.40M | +70.9% | +1575.9% |
| June 30, 2022 | $382.0K | -89.2% | -88.7% |
| March 31, 2022 | $3.38M | -2.6% | -9.7% |
| September 30, 2021 | $3.75M | +32.4% | +5.6% |
- ImageneBio, Inc. showed a decrease of -77.1% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, ImageneBio, Inc.’s total revenue has declined by 91.3% (from $9.19 million to $800.0 thousand).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: